Celltrion Healthcare Competitors and Similar CompaniesClear all
Celltrion Healthcare's competitors and similar companies include CureVac, Candel Therapeutics, Amolyt Pharma and OBI Pharma.
 Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | |||
Founding Date | Founding Date 2002 | Founding Date 2000 | Founding Date 1999 | Founding Date 2015 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Incheon, KR HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Needham, US HQ | Locations Écully, FR HQ Cambridge, US | Locations TW HQ San Diego, US |
Employees | Employees 6301% increase | Employees 82517% decrease | Employees 50 | Employees 373% decrease | Employees 124 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 648.3 m | Valuation ($) 176.8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ₩2t (FY, 2022) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) NT$62.7m (FY, 2024) |
Cost of goods | Cost of goods ₩1.4t (FY, 2022) | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods NT$139m (FY, 2024) |
Gross profit | Gross profit ₩664.7b (FY, 2022) | Gross profit €534.4m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit (NT$63.2m) (FY, 2024) |
Net income | Net income ₩147.2b (FY, 2022) | Net income €162.2m (FY, 2024) | Net income ($38.2m) (FY, 2025) | Net income N/A | Net income (NT$2.5b) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1b | Total funding raised $ 64.6m | Total funding raised $ 93.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company
OBI Pharma
HQ
TW
Employees
124
OBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
View company